Nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC
Prof Ahmed Kaseb - MD Anderson Cancer Center, Houston, USA
4 Oct 2019
CheckMate 459: Safety and efficacy of nivolumab versus sorafenib as a first-line...
Dr Thomas Yau - The University of Hong Kong, Hong Kong
4 Oct 2019
Health-related quality of life for patients with metastatic pancreatic cancer: U...
Prof Eric Van Cutsem and Dr Teresa Macarulla
2 Oct 2019
Key developments in pancreatic cancer from ESMO 2019
Prof Eileen O'Reilly and Dr Ian Chau
2 Oct 2019
Radiotherapy for liver cancer, and neoadjuvant therapy for rectal cancer
Dr Parag Parikh - Mayo Clinic, Rochester, USA
17 Jul 2019
Applied precision cancer medicine in advanced biliary tract cancer
Dr Hossein Taghizadeh - Medical University of Vienna, Vienna, Austria
15 Jul 2019
Treating HER2-mutant advanced biliary tract cancer with neratinib
Dr James Harding - Memorial Sloan kettering Cancer Center, New York, USA
15 Jul 2019
Latest advances in pancreatic cancer treatment and impact on practice
Prof Eric Van Cutsem and Dr Talia Golan
10 Jul 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
24 Jun 2019
Comment: POLO III trial for metastatic pancreatic cancer
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
24 Jun 2019
Comment: Laparoscopic versus open resection for colorectal liver metastases
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
13 Jun 2019
ABC-06 results: Second-line ASC mFOLFOX chemotherapy for biliary tract cancer
Dr Angela Lamarca - The Christie NHS Foundation Trust, Manchester, UK
11 Jun 2019
